
AI assistants that triage deviations, draft investigations and surface root causes - integrated with TrackWise, Veeva QMS and your MES, with full GxP traceability.
Quick Answer
NeoBram builds AI deviation management for pharma that auto-triages deviation severity, drafts investigation reports, and surfaces likely root causes from MES and batch records - cutting investigation cycle time 40-60% while preserving GxP and 21 CFR Part 11 compliance.
Why This Matters
A typical pharma site logs 2,000-10,000 deviations per year. Each major deviation takes 20-60 hours of QA time to investigate. Backlogs delay batch release, tie up inventory and push QA teams to burnout.
AI now does the heavy lifting on triage, evidence collection, and root-cause hypothesis - while QA professionals retain authority on classification, CAPA decisions and approval.
We deploy deviation AI that integrates with TrackWise, Veeva QMS, MES, LIMS and batch records - and is designed for GxP from day one: full audit trail, electronic signatures, locked-down model versioning and validation packs ready for inspection.
Our Tech Stack
Architecture Deep-Dive
Classifies new deviations by likely severity (minor / major / critical), product impact and regulatory reportability within minutes of creation.
Drafts the initial investigation narrative using batch records, MES events, lab results and similar historical deviations - the QA investigator edits and approves.
Surfaces the top 3-5 candidate root causes ranked by historical match, with supporting evidence and recommended verification tests.
Built for regulated environments: full audit trail, locked model versions, electronic signatures, validation pack and human approval gates.
Enterprise AI demands enterprise-grade security. Every solution we deploy follows strict data sovereignty, safety, and compliance standards.
FAQ
Ready to unlock the full potential of AI for your enterprise? Let's build something extraordinary together.